Literature DB >> 11262529

Molecular epidemiology of respiratory syncytial virus.

P A Cane1.   

Abstract

Human respiratory syncytial virus (RSV) is the major cause of lower respiratory tract disease in infants. It is unusual in that it causes repeated infections throughout life. Despite considerable efforts there is as yet no satisfactory vaccine available. This paper reviews the molecular epidemiology of the RSV and describes the complex genotypic structure of RSV epidemics. The evolution of the virus is discussed, with particular reference to the antigenic and genetic variability of the attachment glycoprotein. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2001        PMID: 11262529     DOI: 10.1002/rmv.305

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  75 in total

1.  Structural identifiability analysis of some highly structured families of statespace models using differential algebra.

Authors:  Gabriella Margaria; Eva Riccomagno; Lisa J White
Journal:  J Math Biol       Date:  2004-03-03       Impact factor: 2.259

Review 2.  Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis.

Authors:  Karen A Robinson; Olaide A Odelola; Ian J Saldanha
Journal:  Cochrane Database Syst Rev       Date:  2016-07-20

3.  Natural history of human respiratory syncytial virus inferred from phylogenetic analysis of the attachment (G) glycoprotein with a 60-nucleotide duplication.

Authors:  Alfonsina Trento; Mariana Viegas; Mónica Galiano; Cristina Videla; Guadalupe Carballal; Alicia S Mistchenko; José A Melero
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  Molecular analysis of respiratory syncytial virus reinfections in infants from coastal Kenya.

Authors:  Paul D Scott; Rachel Ochola; Mwanajuma Ngama; Emelda A Okiro; D James Nokes; Graham F Medley; Patricia A Cane
Journal:  J Infect Dis       Date:  2005-11-17       Impact factor: 5.226

5.  Group B strains of human respiratory syncytial virus in Saudi Arabia: molecular and phylogenetic analysis.

Authors:  Fahad N Almajhdi; Mohamed A Farrag; Haitham M Amer
Journal:  Virus Genes       Date:  2013-12-27       Impact factor: 2.332

6.  Amino acid variation within the fusion protein of respiratory syncytial virus subtype A and B strains during annual epidemics in South Africa.

Authors:  Elizabeth Agenbach; Caroline T Tiemessen; Marietjie Venter
Journal:  Virus Genes       Date:  2005-03       Impact factor: 2.332

Review 7.  Structural, antigenic and immunogenic features of respiratory syncytial virus glycoproteins relevant for vaccine development.

Authors:  José A Melero; Vicente Mas; Jason S McLellan
Journal:  Vaccine       Date:  2016-09-28       Impact factor: 3.641

8.  Single-batch production of recombinant human polyclonal antibodies.

Authors:  Lars S Nielsen; Alexandra Baer; Christian Müller; Kristian Gregersen; Nina T Mønster; Søren K Rasmussen; Dietmar Weilguny; Anne B Tolstrup
Journal:  Mol Biotechnol       Date:  2010-07       Impact factor: 2.695

9.  Genetic variability of group A human respiratory syncytial virus strains circulating in Germany from 1998 to 2007.

Authors:  Janine Reiche; Brunhilde Schweiger
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

10.  Molecular and clinical characteristics of respiratory syncytial virus infections in hospitalized children.

Authors:  R Mentel; U Ilgert; U Wegner; K Zimmerman; R Bruns; L Gürtler
Journal:  Med Microbiol Immunol       Date:  2005-01       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.